•
Sep 30, 2022

Solid Biosciences Q3 2022 Earnings Report

EPS
-$2.71
Previous year: -$2.4
+12.9%
Cash and Equivalents
$48.8M
Previous year: $110M
-55.5%
Free Cash Flow
-$21.3M
Previous year: -$18.7M
+14.0%
Total Assets
$184M
Previous year: $249M
-25.9%

Solid Biosciences

Solid Biosciences